HOME >> BIOLOGY >> NEWS
Georgia Tech accelerates drug discovery with new IBM supercomputing cluster

ins, to aid in the development of more targeted drugs to treat such diseases.

"Universities today are looking for the fastest, most innovative and cost-efficient systems to help their intellectual communities translate the research they generate into viable information for the commercial market," said Doug Balog, vice president, IBM BladeCenter. "With the Cluster 1350 system based on the AMD Opteron LS20 IBM BladeCenter, students and faculty of Georgia Tech are gaining the processing power and system resources they need to make more accurate decisions in research and raise the profile of the Institute among the nation's most elite research facilities."

"Only the most technologically savvy universities are able to compete in the field of drug discovery and bioinformatics," said Mike Cassidy, president and CEO of the Georgia Research Alliance. "Georgia Tech's focus on top-of-the-line technology and research facilities and the attraction of Dr. Jeff Skolnick and other world-class scholars will raise its presence in this competitive market and attract some of the nation's brightest students to join our research team to advance medicines that will improve the well-being of people everywhere."

BellSouth worked closely with Georgia Tech and IBM to design a unique, reliable hosting environment to support the high power density supercomputing cluster.

"With our hosting background, we had the flexibility and experience to quickly create a one-of-a-kind solution that could support Georgia Tech, IBM and the supercomputing cluster that will power the groundbreaking research of Dr. Skolnick," said Bill Smith, BellSouth's Chief Technology Officer.

The new supercomputer, capable of a peak performance of more than 16 TeraFlops, consists of a cluster of 1,000 AMD Opteron processor-based LS20 nodes for IBM BladeCenter systems (total of 4,000 core processors) running Red Hat Linux 4 on the infrastructure nodes and Scientific Linux on the com
'"/>

Contact: David Terraso
d.terraso@gatech.edu
404-385-2966
Georgia Institute of Technology
8-Feb-2006


Page: 1 2 3 4

Related biology news :

1. Educators in Georgia and Maryland earn top 2006 Mentoring Awards from AAAS
2. Nature meets technology at Georgia Techs conference on bio-inspired design
3. Georgia Tech computer program designed to halt pandemics installed in Georgia
4. New Georgia Tech probe revolutionizes nano imaging
5. Georgia Tech develops technology for more compact, inexpensive spectrometers
6. Georgia Tech study: Short glass shapes cause over-pouring of alcohol
7. Are hurricanes increasing? Ask a Georgia pine tree
8. Georgia Tech develops mass spectrometry device that analyzes proteins faster and at a lower cost
9. NIH awards Georgia Tech/Emory $11.5 M for nano cardiology research
10. Georgia Tech research reveals how biomaterial properties control cellular responses
11. Georgia Tech research indicates immune complications associated with combination medical devices

Post Your Comments:
(Date:12/5/2014)... MOUNTAIN VIEW, Calif. , Dec. 4, 2014 ... and safety has boosted investments in new testing ... products has also given rise to a range ... driven by the requirements of Generation Y, which ... digital technologies. As a result, product development strategies ...
(Date:12/4/2014)... , Dec. 3, 2014  Crossmatch™, a leading ... that its DigitalPersona ® Pro Enterprise software ... been deployed throughout First Bank branch locations in ... South Carolina and Virginia. First Bank, a ... Southern Pines, North Carolina , selected the ...
(Date:12/3/2014)... 2014 As part of our commitment to ... pleased to announce the release of a new reader ... the workforce data that they need. The ... by existing readers. Many such devices have serious shortcomings ... technology. Older models force users to navigate numerous complicated ...
Breaking Biology News(10 mins):Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Inception Technologies to Release New Biometric Reader 2
(Date:12/17/2014)... 17, 2014 Based on the ... surgical imaging market is dominated by four major ... imaging market. These players include GE Healthcare (U.K.), ... (Germany). , Full Report Copy at ... Healthcare can be attributed to its strong product ...
(Date:12/17/2014)... December 17, 2014 Ipsen Biopharmaceuticals, ... IPN; ADR: IPSEY), today announced that ... as Somatuline®) was approved by the U.S. Food ... gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult patients with ... metastatic disease to improve progression-free survival (PFS). , ...
(Date:12/17/2014)... December 17, 2014 Xeno Diagnostics ... following its most recent COLA inspection. Xeno has ... a national healthcare accreditation organization. Accreditation is earned ... quality in day-to-day operations, demonstrate continued accuracy in ... rigorous on-site laboratory survey. , While ...
(Date:12/17/2014)... Dec. 16, 2014  Vermillion, Inc. (NASDAQ: ... disease, today announced the next step in its expanded ... solutions provider with the naming of current Chief Operating ... Executive Officer, while current Chairman of the Board and ... as Chairman. These changes are effective January 1, 2015. ...
Breaking Biology Technology:Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 3Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4
Cached News: